Enhancing Immune Response to HIV Infection Using MPC-Based Treatment Scheduling

Proceedings of the American Control Conference

Volumn 2, Issue , 2003, Pages 1182-1187

  Zurakowski, Ryan ^a   Teel, Andrew R ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; COMPUTER SIMULATION; PATIENT TREATMENT; VIRUSES;

IMMUNE RESPONSE;

PREDICTIVE CONTROL SYSTEMS;

EID: 0142138698     PISSN: 07431619     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (21)

1. H. K. Altes, D. Wodarz, and V. Jansen. The dual role of CD4 t helper cells in the infection dynamics of HIV and their importance for vaccination. Journal of Theoretical Biology, 214, 2002.
2. R. Arnaout, M. Nowak, and D. Wodarz. HIV-1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing? Proceedings of the Royal Society of London in Biology, 267, 2000.
3. M. Brandt and G. Chen. Feedback control of a biodynamical model of HIV-1. IEEE Transactions on Biomedical Engineering, 48(7), 2001.
4. R. Davey, N. Bhat, C. Yoder, T.-W. Chun, J. Metcalf, R. Dewar, V. Natarajan, R. Lempicki, J. Adelsberger, K. Miller, J. Kovacs, M. Polis, R. Walker, J. Falloon, H. Masur, D. Gee, M. Baseler, D. Dimitrov, A. Fauci, and H. C. Lane. HIV-1 and T cell dynamics after interuption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proceedings of the National Academy of Sciences, 96(26), 1999.
5. F. M. C. de Souza. Modeling the dynamics of HIV-1 and CD4 and CD8 lymphocyctes. IEEE Engineering in Medicine and Biology Magazine, 18(1), 1999.
6. D. Finzi, J. Blankson, J. Siliciano, J. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. Quinn, R. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, and R. Siliciano. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine, 5(5), 1999.
7. F. Garcia, M. Plana, G. Ortiz, S. Bonhoeffer, A. Soriano, C. Vidal, A. Cruceta, M. Arnedo, C. Gil, G. Pantaleo, T. Pumarola, T. Gallart, D. Nixon, J. Miro, and J. Gatell. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS, 15(9), 2001.
8. T. Gegeny. Simply stated: Surviving with HIV in the HAART era: emerging challenges. Research Initiative/Treatment Action!, 6(3), 2000.
9. G. Grimm, M. J. Messina, A. R. Teel, and S. E. Tuna. Model predictive control when a local control lyapunov function is not available. In Proceedings of the American Control Conference, June 2003 (Submitted).
10. D. Kirschner, S. Lenhart, and S. Serbin. Optimal control of the chemotherapy of HIV. Journal of Mathematical Biology, 35, 1997.
11. C. Manegold, C. Hannoun, A. Wywiol, M. Dietrich, S. Polywka, C. B. Chiwakatal, and S. Gunther. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clinical Infectious Diseases, 32, 2001.
12. D. Mayne, J. B. Rawlings, C. V. Rao, and P. Scokaert. Constrained model predictive control: Stability and optimality. Automatica, 36, 2000.
13. A. Neumann, R. Tubiana, V. Calvez, C. Robert, T.-S. Li, H. Agut, B. Autran, and C. Katlama. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. AIDS, 13, 1999.
14. G. Ortiz, D. Nixon, A. Trkola, J. Binley, X. Jin, S. Bonhoeffer, P. Kuebler, S. Donahoe, M.-A. Demoitie, W. Kakimoto, T. Ketas, B. Clas, J. Heymann, L. Zhang, Y. Cao, A. Hurley, J. Moore, D. Ho, and M. Markowitz. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. Journal of Clinical Immunology, 104, 1999.
15. E. Papasavvas, G. Ortiz, R. Gross, J. Sun, E. C. Moore, J. Heymann, M. Moonis, J. K. Sandberg, L. A. Drohan, B. Gallagher, J. Shull, D. F. Nixon, J. Kostman, and L. Montaner. Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected patients after long-term viral suppression. Journal of Infectious Diseases, 182, 2000.
16. E. Rosenberg, M. Altfeld, S. Poon, M. Phillips, B. Wilkes, R. Eldridge, G. Robbins, R. D'Aquila, P. Goulder, and B. Walker. Immune control of HIV-1 after early treatment of acute infection. Nature, 407, 2000.
17. L. Wein, S. A. Zenios, and M. A. Nowak. Dynamic multidrug therapies for HIV: A control theoretic approach. Journal of Theoretical Biology, 185, 1996.
18. D. Wodarz. Helper-dependent vs. helper-independent CTL responses in HIV infection. Journal of Theoretical Biology, 213, 2001.
19. D. Wodarz, R. Arnaout, M. Nowak, and J. Lifson. Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus. Philosophical Transactions of the Royal Society of London in Biology, 355, 2000.
20. D. Wodarz and V. Jansen. The role of T cell help for anti-viral CTL responses. Journal of Theoretical Biology, 211, 2002.
21. D. Wodarz and M. A. Nowak. Specific therapy regimes could lead to long-term immunological control of HIV. Proceedings of the National Academy of Sciences, 96(25), 1999.